Brain Stimulation for Concussion

N/A

Recruiting

Led By Harm J van der Horn, MD PhD

Research Sponsored by The Mind Research Network

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3 months after start of the study for the individual participant. data will be reported at the conclusion of the study for all participants.

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a new magnetic brain stimulation treatment for patients with ongoing symptoms after a concussion. Participants will have MRI scans before and after 30 short treatment sessions. The study wants to find out

Who is the study for?

This trial is for adults aged 18-64 who have had a mild traumatic brain injury (mTBI) with symptoms lasting more than 3 months. Participants should have experienced altered mental status or loss of consciousness for up to 30 minutes, and post-traumatic amnesia not exceeding 24 hours after the injury.

What is being tested?

The study tests intermittent theta-burst treatment (iTBS) using a MagPro Transcranial Magnetic Stimulator on patients with persistent concussion symptoms. It involves MRI scans before and after thirty short sessions to assess symptom reduction and improvements in brain function.

What are the potential side effects?

Potential side effects may include discomfort at the stimulation site, headache, lightheadedness, or seizures; however, these are generally rare with transcranial magnetic stimulation procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post-treatment (after completion of all sessions, at ~4 weeks), and at 3 months after start of the study for the individual participant. data will be reported at the conclusion of the study for all participants.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post-treatment (after completion of all sessions, at ~4 weeks), and at 3 months after start of the study for the individual participant. data will be reported at the conclusion of the study for all participants.

This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment (after completion of all sessions, at ~4 weeks), and at 3 months after start of the study for the individual participant. data will be reported at the conclusion of the study for all participants. for reporting.